Leadership Team
Anthony Krick
VP of Finance
Mr. Krick joined Milestone as Vice President of Finance in May 2026. Prior to joining Milestone, Mr. Krick served as Vice President, Finance and Chief Accounting Officer at Optinose, Inc., a publicly traded, commercial stage specialty pharmaceutical company. While at Optinose, he was responsible for all finance and accounting activities, including leading the financial process behind the sale of Optinose to Paratek Pharmaceuticals.
Prior to joining Optinose, Mr. Krick served as the Corporate Controller of Verrica Pharmaceuticals, a publicly traded, commercial stage medical dermatology company. Prior to joining Verrica, Mr. Krick served as Executive Director, Financial Planning & Analysis at Strongbridge Biopharma, a publicly traded, commercial stage rare disease company. While at Strongbridge, he was responsible for all financial planning and business partnering activities, as well as transaction support for capital markets and business development activities.
Earlier in his career, Mr. Krick held a number of positions of increasing responsibility at GSK and Endo Pharmaceuticals, including business facing roles supporting commercial and research and development organizations, as well as corporate roles in accounting and reporting. Mr. Krick began his career at Ernst & Young LLP, where he served clients in the biotechnology and pharmaceutical industries.
Mr. Krick received a BS in accounting from Albright College and is a Certified Public Accountant.
